Cabergoline in Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: DRUG: cabergoline
Sponsor: Northwestern University
Collaborators: Lynn Sage Foundation